GPC-3 targeting binding peptide F3 and derivative, probe and application thereof

A targeted combination and derivative technology, applied in the field of biomedicine, can solve the problems of slow imaging background clearance, excessive accumulation of liver metabolism, poor tumor permeability, etc., achieve good tumor targeting and application prospects in diagnosis and treatment, and simple synthesis process , the effect of small molecular weight

Active Publication Date: 2021-04-16
NANJING DRUM TOWER HOSPITAL
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Antibodies used in imaging probes have strong tumor-targeting binding ability, but the large molecular weight and structure of antibodies may lead to the disadvantages of slow imaging background clearance, poor tumor permeability, and more accumulation of liver metabolism, while targeting short peptides These shortcomings can be improved to a certain extent. Short peptide probes have the advantages of easy preparation, fast background clearance, high targeting and deep tumor penetration. Therefore, the development of tumor-targeted binding peptides has important clinical application value for the diagnosis and treatment of HCC.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • GPC-3 targeting binding peptide F3 and derivative, probe and application thereof
  • GPC-3 targeting binding peptide F3 and derivative, probe and application thereof
  • GPC-3 targeting binding peptide F3 and derivative, probe and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Example 1: Phage Display Random Peptide Library Biopanning for GPC-3-specific Binding Peptides.

[0040]1. Coating the target protein: irradiate the sterile polystyrene culture dish with ultraviolet light for 30 min in advance, then add 2 mL of recombinant human GPC-3 protein with a concentration of 100 μg / mL, then put it into an airtight container and place it at 4 Shake gently overnight at ℃, discard the excess coating solution the next day, add 0.5% BSA blocking solution, and incubate at 37 ℃ for 1 h.

[0041] 2. Biopanning of phage display random peptide library: remove the blocking solution and wash 6 times with PBS-T (containing 0.1% Tween-20). Take 10 μL of the original phage display random peptide library (original library titer 2 × 1013 pfu / mL), dilute and mix with 2 mL of 0.1% PBS-T, add to the coated protein culture dish, and incubate at room temperature for 2.5 h .

[0042] 3. Remove unbound phage display peptides: wash 10 times with 0.1% PBS-T (concentrat...

Embodiment 2

[0046] Example 2: ELISA of monoclonal phage displaying F3 peptide.

[0047] 1. Target coating: prepare 3 coated plates, including protein plate, HepG-2 plate and PC-3 plate. Protein plate: Add recombinant human GPC-3 protein at 100 μg / mL to 100 μL / well of a 96-well plate, overnight at 4 °C; HepG-2 plate: HepG-2 is a human liver cancer cell line positive for GPC-3 expression, Add 2 × 105 cells / well to a 96-well plate, culture overnight at 37 °C, 5% CO2; PC-3 plate: PC-3 is a human prostate cancer cell line negative for GPC-3 expression, add 2 × 10 cells to a 96-well plate 105 cells / well, cultured overnight at 37°C, 5% CO2.

[0048] 2. Block the target: discard the supernatant from the coated plate, add 200 μL / well of 0.5% BSA blocking solution, and block at 4 °C for 2 hours. Before sealing the cell-coated plate, the supernatant was discarded, 120 μL / well of 4% paraformaldehyde was added, left at room temperature for 15 min, washed twice with 0.5% PBS-T, and then blocked.

[...

Embodiment 3

[0055] Example 3: Verification of cell binding and target blocking verification.

[0056] 1. According to the polypeptide sequence F3 obtained in Example 1, carry out chemical synthesis and label the fluorescent dye Rhodamine B (RhodamineB, RhoB), and chemically synthesize the control polypeptide G7 (sequence is CGGGGGGGC, the disulfide bond at the first and last ends is a cyclic peptide) and Label RhoB to obtain fluorescent probes RhoB-F3 and RhoB-G7.

[0057] 2. Cell plating: HepG-2 and PC-3 cells were plated on 12-well cell culture plates at 1.5 × 104 cells / well, and cultured overnight at 37 °C and 5% CO2.

[0058] 3. Blocking: Discard the supernatant, wash with PBS, add 4% paraformaldehyde, let stand at room temperature for 20 min, then wash with PBS, add 1% BSA blocking solution, and incubate at 37 °C for 1 h.

[0059] 4. Fluorescent peptide probe binding: Discard the blocking solution, add RhoB-F3 fluorescent probe or control probe RhoB-G7 at a concentration of 10 μM, r...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a GPC-3 targeting binding peptide F3, and a derivative, a probe and an application thereof, the amino acid sequence of the GPC-3 targeting binding peptide F3 is SEQ ID No.1: CEQAYQYSC, the polypeptide space structure of the GPC-3 targeting binding peptide F3 is a cyclic peptide, and cysteine at the head and tail ends forms a disulfide bond; the GPC-3 targeting binding peptide F3 can be specifically bound to a tumor molecular marker GPC-3 and does not specifically bind to expression negative cells. After successful screening, repeated experiments prove that the GPC3 targeted binding peptide F3, the derivative and the probe thereof have definite GPC3 targeted binding performance and can be applied to liver cancer molecular pathological diagnosis, PET / CT image diagnosis and treatment drugs.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and specifically relates to a GPC-3 targeting binding peptide F3 and its derivatives, probes and applications. Background technique [0002] Hepatocellular carcinoma (HCC) is one of the common malignant tumors of the digestive system in my country. About 80% of primary liver cancers are hepatocellular carcinoma, and other types such as intrahepatic cholangiocarcinoma (ICC) account for about 20% . Among men under the age of 60, liver cancer is the most common malignant tumor with the highest mortality rate, followed by lung cancer, gastric cancer, and esophageal cancer. At present, the treatment for hepatocellular carcinoma mainly includes surgery, chemotherapy, and immunotherapy. Traditional drug therapy is limited by poor tumor targeting, insufficient drug concentration in tumor tissue, and off-target effects. The curative effect is not ideal, and the 5-year survival rate is only about 12.5...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K7/06A61K49/00A61K51/08A61K47/64A61P35/00A61K103/00
Inventor刘宝瑞颜家耀余潇潇
OwnerNANJING DRUM TOWER HOSPITAL